Search for: "Barr Pharmaceuticals Inc"
Results 61 - 80
of 162
Sort by Relevance
|
Sort by Date
8 Dec 2010, 10:42 am
Barr Labs., Inc., (In re Tamoxifen Citrate Antitrust Litig.), 466 F.3d 187 (2d Cir. 2005), compelled it to do so. [read post]
8 Dec 2010, 2:20 am
Highlights this week included: India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
9 Nov 2010, 3:09 pm
On March 19, 2007, Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc. [read post]
24 Sep 2010, 1:15 pm
Barr Labs., Inc., 575 F.3d 1341 (Fed. [read post]
9 Sep 2010, 4:01 pm
"Reuters had written:On April 29, a three-judge panel in New York upheld a lower court's ruling dismissing objections to Bayer AG paying Teva Pharmaceutical Industries Inc's Barr Laboratories to prevent it from bringing to market a version of the anthrax drug Cipro.But the panel invited further review by the full nine-judge panel of the U.S. [read post]
8 Sep 2010, 3:21 pm
Barr Labs., Inc. [read post]
2 Sep 2010, 10:51 am
Barr Labs., Inc., 575 F.3d 1341 (Fed. [read post]
13 Aug 2010, 12:46 pm
Barr Labs., Inc., 251 F.3d 955, 970 (Fed. [read post]
28 Jul 2010, 5:04 pm
Barr Labs., Inc., 251 F.3d 955, 968 (Fed. [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
30 Jun 2010, 5:52 am
Mylan Pharmaceuticals Inc. et al. [read post]
29 Jun 2010, 6:01 pm
Mylan Pharmaceuticals Inc. et al. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
14 Jun 2010, 6:30 pm
Geneva Pharmaceuticals, Inc., 344 F.3d 1294 (11th Cir. 2003). [read post]
14 Jun 2010, 6:12 pm
Barr Labs., Inc., 437 F.3d 1181, 1193 (Fed. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
8 Jun 2010, 2:29 pm
Barr Labs., Inc. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
